Introduction: Who Should Undergo Diagnostics
Every woman who gives birth should be carefully monitored for signs of postpartum hemorrhage during and after delivery. This is because postpartum hemorrhage, commonly known as PPH, can occur in anyone, regardless of whether they have known risk factors. Studies show that about 20 percent of women who experience this serious complication had no identifiable risk factors beforehand, which means healthcare providers must remain vigilant with every single birth.[9]
Healthcare providers typically begin monitoring for PPH immediately after the baby is born and continue this surveillance for at least 24 hours after delivery. However, women should know that bleeding problems can arise much later. Primary PPH occurs within the first 24 hours after childbirth, while secondary or late PPH can happen anytime from 24 hours up to 12 weeks after delivery.[1][2] This extended timeframe means that women need to stay alert to warning signs even after they leave the hospital and return home.
Women who fall into certain high-risk categories should receive especially close monitoring. These include mothers carrying multiple babies, those with a history of PPH in previous pregnancies, women with placental complications such as placenta previa or placental abruption, and those with pre-existing bleeding disorders. Mothers who have had a prolonged labor, an overdistended uterus due to excess amniotic fluid or a large baby, or who require assisted delivery with forceps or vacuum are also at increased risk.[4][9] For these women, healthcare teams often prepare additional resources and monitoring protocols before delivery even begins.
Any woman who notices concerning symptoms after giving birth should seek diagnostic evaluation immediately, regardless of how much time has passed since delivery. Warning signs include heavy vaginal bleeding that soaks through one or more pads in an hour, passing blood clots larger than a golf ball, feeling dizzy or faint, having a racing heartbeat, experiencing blurred vision, or developing pale or clammy skin. Pain and swelling in the vaginal or perineal area can also signal internal bleeding that requires urgent assessment.[1][7]
Diagnostic Methods
Diagnosing postpartum hemorrhage begins with accurate measurement of blood loss, though this seemingly simple task presents significant challenges. Traditionally, healthcare providers relied on visual estimation to assess how much blood a woman lost during and after delivery. However, research has shown that visual assessment routinely underestimates actual blood loss by a substantial margin, which can delay recognition of PPH and appropriate treatment.[17] This is why many hospitals now use more objective measurement methods.
One of the most effective diagnostic approaches involves using a simple, low-cost collection device called a drape. This calibrated underbody drape collects and measures blood loss more accurately than visual inspection alone. When blood is collected in such a device, healthcare providers can see exact volumes marked on the collection bag, removing much of the guesswork. A landmark study found that objectively measuring blood loss using this method, combined with bundled treatment protocols, resulted in a 60 percent reduction in severe bleeding cases.[17]
The diagnostic threshold for PPH has evolved over time. While older definitions specified blood loss exceeding 500 milliliters after vaginal delivery or 1,000 milliliters after cesarean delivery, current medical guidance recognizes that these thresholds don’t tell the complete story. Modern diagnostic criteria define PPH as cumulative blood loss of 1,000 milliliters or more, regardless of delivery method, or any amount of blood loss accompanied by signs and symptoms of hypovolemia within 24 hours after birth.[2][3] Hypovolemia refers to decreased blood volume that affects how well your organs receive oxygen-rich blood.
Physical examination and vital sign monitoring form crucial components of PPH diagnosis. Healthcare providers regularly check heart rate, blood pressure, and other vital signs during and after delivery. A rapid heartbeat, known as tachycardia, often serves as an early warning sign that the body is trying to compensate for blood loss. Similarly, a drop in blood pressure indicates that significant bleeding has occurred. Checking the firmness of the uterus is also essential, as a soft, poorly contracted uterus strongly suggests uterine atony, which is the most common cause of PPH, accounting for up to 80 percent of cases.[1][5]
Laboratory tests play an important supporting role in diagnosis and management. A complete blood count measures the hematocrit level, which indicates the proportion of red blood cells in the blood. A decreased hematocrit confirms that significant blood loss has occurred. Healthcare teams also assess clotting factors through specialized blood tests, especially when they suspect a bleeding disorder might be contributing to the hemorrhage. These tests help identify whether the blood’s ability to clot properly has been compromised, which can occur with conditions like disseminated intravascular coagulation, a serious complication where abnormal clotting and bleeding happen simultaneously throughout the body.[1][8]
To systematically identify the underlying cause of PPH, healthcare providers use a memory tool called the “Four T’s” mnemonic, which stands for Tone, Trauma, Tissue, and Thrombin. This framework guides diagnostic evaluation by helping providers quickly consider all possible causes. Tone refers to uterine atony when the womb fails to contract properly. Trauma includes tears in the cervix, vagina, or perineum, as well as uterine rupture or inversion. Tissue involves retained placental fragments or membranes that prevent the uterus from contracting effectively. Thrombin refers to blood clotting disorders, whether pre-existing conditions or those acquired during pregnancy.[5][9]
Physical examination techniques help distinguish between these causes. For instance, if the uterus feels soft and boggy to the touch, uterine atony is likely. If the uterus is firm but bleeding continues, providers carefully examine the birth canal for tears or lacerations that might be bleeding. A thorough inspection of the placenta after delivery helps determine whether all placental tissue was expelled completely, as retained fragments can prevent proper uterine contraction and lead to continued bleeding.[8]
Advanced imaging studies are sometimes needed when the source of bleeding is not immediately apparent through physical examination. Ultrasound imaging can reveal retained placental tissue inside the uterus or identify blood collecting in hidden spaces, forming a hematoma. In complex cases where bleeding continues despite initial interventions, or when surgical complications are suspected, computed tomography (CT) scans may provide detailed images to guide further treatment decisions.[1]
Diagnostics for Clinical Trial Qualification
While the provided sources do not contain specific information about diagnostic tests and methods used as standard criteria for enrolling patients in clinical trials for postpartum hemorrhage, the general diagnostic approaches described above form the foundation for identifying and classifying PPH cases. Clinical research studies typically require precise documentation of blood loss volumes, timing of symptom onset, underlying causes according to the Four T’s classification, and measurement of specific laboratory values such as hemoglobin and hematocrit levels before and after the hemorrhagic event.
Research protocols often mandate the use of quantitative blood loss assessment rather than visual estimation to ensure accurate case identification and comparison across study participants. Documentation of vital sign changes, including the degree and duration of blood pressure drops and heart rate elevations, helps researchers categorize the severity of PPH cases. These standardized diagnostic criteria ensure that clinical trials enroll appropriate participants and can accurately measure whether investigational treatments improve outcomes compared to current standard care.


